Brief: Rhythm Pharmaceuticals Q2 Net Income USD -32.263 Million
06/08/2024 12:00
Aug 06 (Reuters) - Rhythm Pharmaceuticals Q2 product revenue USD 29.078 million. * Q2 operating income USD -40.478 million
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand